美国子宫内膜异位症手术相关的增量直接与间接费用负担
基于2006-2014年Truven Health MarketScan数据库的回顾性队列研究,比较124,530例子宫内膜异位症手术患者与37,106例未手术患者的费用。手术组术后12个月调整后年均直接费用约19,203美元,约为未手术组6,365美元的三倍,增量直接费用12,838美元;增量间接费用3,240美元。
要点
- 手术组术后12个月调整后年均直接费用19,203美元,未手术组6,365美元,增量12,838美元。
- 手术组年均间接费用8,843美元,未手术组5,603美元,增量3,240美元。
- 无论手术类型,索引手术费用(7,268美元)是增量直接费用的最大单项贡献。
核心结论
- 接受手术的子宫内膜异位症患者较未手术患者因医疗利用产生显著更高的直接费用,因缺勤或短期残疾产生显著更高的间接费用。
- 无论手术类型,索引手术费用对总医疗支出贡献重大。
研究设计与样本
- 回顾性队列研究,数据来自Truven Health MarketScan Commercial and Health and Productivity Management数据库2006-2014年。
- 纳入18-49岁子宫内膜异位症患者,手术组n=124,530,未手术组n=37,106。
- 间接费用仅在有生产力数据的患者中评估。
主要发现
- 手术组术后12个月调整后年均总直接费用19,203美元(SD 7,133),未手术组6,365美元(SD 2,364),平均增量年直接费用12,838美元。
- 手术费用均值7,268美元(SD 7,975),是增量年直接费用的最大单项贡献。
- 手术组年均总间接费用估计8,843美元,未手术组5,603美元,平均增量年间接费用3,240美元。
- 手术组术后索引期医疗服务利用显著高于未手术组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare direct and indirect costs between endometriosis patients who underwent endometriosis-related surgery (surgery cohort) and those who have not received surgery (no-surgery cohort). DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Endometriosis patients (aged 18-49 years) with (n = 124,530) or without (n = 37,106) a claim for endometriosis-related surgery were identified from the Truven Health MarketScan Commercial and Health and Productivity Management databases for 2006-2014. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Primary outcomes were healthcare utilization during 12-month pre- and post-index periods, annual direct (healthcare) and indirect (absenteeism and short- and long-term disability) costs during the 12-month post-index period (in 2014 US dollars). Indirect costs were assessed for patients with available productivity data. RESULT(S): Patients in the surgery cohort had significantly higher healthcare resource utilization during the post-index period and had mean annual total adjusted post-index direct costs approximately three times the costs among patients in the no-surgery cohort ($19,203 [SD $7,133] vs. $6,365 [SD $2,364]; average incremental annual direct cost = $12,838). The mean cost of surgery ($7,268 [SD $7,975]) was the single largest contributor to incremental annual direct cost. Mean estimated annual total indirect costs were $8,843 (surgery cohort) vs. $5,603 (no-surgery cohort); average incremental annual indirect cost = $3,240. CONCLUSION(S): Endometriosis patients who underwent surgery, compared with endometriosis patients who did not, incurred significantly higher direct costs due to healthcare utilization and indirect costs due to absenteeism or short-term disability. Regardless of the surgery type, the cost of index surgery contributed substantially to the total healthcare expenditure.
引用
- Soliman AM, Taylor HS, Bonafede M, et al. Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fertil Steril. 2017. PMID: 28476181. doi:10.1016/j.fertnstert.2017.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。